KR100440544B1 - 양이온 교환수지 제제 - Google Patents
양이온 교환수지 제제 Download PDFInfo
- Publication number
- KR100440544B1 KR100440544B1 KR10-1999-0031005A KR19990031005A KR100440544B1 KR 100440544 B1 KR100440544 B1 KR 100440544B1 KR 19990031005 A KR19990031005 A KR 19990031005A KR 100440544 B1 KR100440544 B1 KR 100440544B1
- Authority
- KR
- South Korea
- Prior art keywords
- exchange resin
- cation exchange
- formulation
- polystyrene sulfonate
- binder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003729 cation exchange resin Substances 0.000 title claims abstract description 59
- 239000003814 drug Substances 0.000 title 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 57
- 239000000203 mixture Substances 0.000 claims abstract description 37
- 238000009472 formulation Methods 0.000 claims abstract description 32
- 239000006188 syrup Substances 0.000 claims abstract description 29
- 235000020357 syrup Nutrition 0.000 claims abstract description 29
- 239000011734 sodium Substances 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims abstract description 19
- 239000011230 binding agent Substances 0.000 claims abstract description 18
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 16
- 239000003349 gelling agent Substances 0.000 claims abstract description 16
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 16
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 16
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 8
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 7
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229950008138 carmellose Drugs 0.000 claims abstract description 7
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 7
- 239000008187 granular material Substances 0.000 claims description 23
- 239000001856 Ethyl cellulose Substances 0.000 claims description 6
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 6
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 6
- 229920001249 ethyl cellulose Polymers 0.000 claims description 6
- 229960002796 polystyrene sulfonate Drugs 0.000 claims description 6
- 239000011970 polystyrene sulfonate Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 claims description 4
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 claims 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 14
- 230000035622 drinking Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 2
- 238000001879 gelation Methods 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 238000005469 granulation Methods 0.000 description 12
- 230000003179 granulation Effects 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 229920000609 methyl cellulose Polymers 0.000 description 7
- 239000001923 methylcellulose Substances 0.000 description 7
- 235000010981 methylcellulose Nutrition 0.000 description 7
- 108010011485 Aspartame Proteins 0.000 description 6
- 239000000605 aspartame Substances 0.000 description 6
- 235000010357 aspartame Nutrition 0.000 description 6
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 6
- 229960003438 aspartame Drugs 0.000 description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 6
- 235000015424 sodium Nutrition 0.000 description 5
- 229940083542 sodium Drugs 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 229940023913 cation exchange resins Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000013011 mating Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003957 anion exchange resin Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 229920003117 medium viscosity grade hydroxypropyl cellulose Polymers 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000282832 Camelidae Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 208000002682 Hyperkalemia Diseases 0.000 description 2
- 208000033626 Renal failure acute Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 201000011040 acute kidney failure Diseases 0.000 description 2
- 208000012998 acute renal failure Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- ZVOIHZBVHUVVKM-UHFFFAOYSA-N C=CC1=CC=CC=C1.[Ca] Chemical compound C=CC1=CC=CC=C1.[Ca] ZVOIHZBVHUVVKM-UHFFFAOYSA-N 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 244000093965 Triphasia trifolia Species 0.000 description 1
- 235000008693 Triphasia trifolia Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- JJMIAJGBZGZNHA-UHFFFAOYSA-N sodium;styrene Chemical compound [Na].C=CC1=CC=CC=C1 JJMIAJGBZGZNHA-UHFFFAOYSA-N 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
물 질 명 | 중량부 |
양이온 교환수지 | 100 |
CMC-Na | 1.67 |
HPC-M | 6.67 |
아스파탐 | 0.15 |
메트로즈 SM-100 | 0.07 |
합 계 | 108.56 |
물 질 명 | 중량부 |
양이온 교환수지 | 100 |
CMC-Na | 1.67 |
HPC-M | 6.67 |
아스파탐 | 0.30 |
메트로즈 SM-100 | 1.37 |
합 계 | 110.01 |
물 질 명 | 침강속도(mm/min) |
양이온 교환수지 | 2.4743 |
드라이시럽 1 | 0.1527 |
드라이시럽 2 | 0.1675 |
제형 | 복용방법 | 평가항목 | +4 | +3 | +2 | +1 | 0 | -1 | -2 | -3 | -4 | 합계 |
양이온교환수지 | 현탁 | 맛 | 0 | 1 | 0 | 2 | 12 | 9 | 14 | 9 | 6 | 53 |
마시기편함 | 0 | 1 | 4 | 3 | 5 | 8 | 15 | 10 | 7 | 53 | ||
그대로 | 맛 | 0 | 0 | 1 | 2 | 8 | 11 | 5 | 9 | 13 | 49 | |
마시기편함 | 0 | 1 | 1 | 1 | 6 | 7 | 8 | 12 | 14 | 50 | ||
드라이시럽 | 현탁 | 맛 | 0 | 7 | 11 | 14 | 6 | 9 | 3 | 2 | 1 | 53 |
마시기편함 | 1 | 7 | 10 | 5 | 11 | 6 | 7 | 3 | 2 | 52 | ||
개선도 | 6 | 10 | 9 | 18 | 3 | 4 | 1 | 2 | 0 | 53 | ||
그대로 | 맛 | 2 | 3 | 15 | 14 | 11 | 5 | 3 | 0 | 0 | 53 | |
마시기편함 | 2 | 6 | 6 | 4 | 9 | 9 | 6 | 8 | 2 | 52 | ||
개선도 | 7 | 15 | 9 | 7 | 1 | 7 | 3 | 1 | 0 | 50 |
제형 | 복용방법 | 맛 | 마시기 편함 | 개선도 |
양이온 교환수지 | 현탁 | -83 | -82 | |
그대로 | -96 | -109 | ||
드라이시럽 | 현탁 | +32 | +13 | +78 |
그대로 | +50 | -11 | +82 |
Claims (11)
- 양이온 교환수지로서의 폴리스티렌술폰산금속염 및 겔화제로서의 카멜로스나트륨(CMC-Na)으로 된 양이온 교환수지 제제.
- 제1항에 있어서, 제형이 과립제, 산제 또는 드라이시럽인 양이온 교환수지 제제.
- 삭제
- 제1항에 있어서, 폴리스티렌술폰산금속염이 폴리스티렌술폰산칼슘 또는 폴리스티렌술폰산나트륨인 양이온 교환수지 제제.
- 삭제
- 제2항에 있어서, 양이온 교환수지가 폴리스티렌술폰산칼슘 또는 폴리스티렌술폰산나트륨인 양이온 교환수지 제제.
- 제1항, 제2항, 제4항 및 제6항 중 어느 한 항에 있어서, 결합제를 더 포함하는 양이온 교환수지 제제.
- 제7항에 있어서, 결합제가 덱스트린, 결정셀룰로오스, 히드록시프로필셀룰로오스(HPC) 및 에틸셀룰로오스(EC)로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 물질인 양이온 교환수지 제제.
- 제7항에 있어서, 결합제가 히드록시프로필셀룰로오스(HPC)인 양이온 교환수지 제제.
- 제9항에 있어서, 양이온 교환수지가 폴리스티렌술폰산칼슘인 양이온 교환수지 제제.
- 제 10항에 있어서, 제형이 드라이시럽인 양이온 교환수지 제제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1998-217328 | 1998-07-31 | ||
JP21732898 | 1998-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000012062A KR20000012062A (ko) | 2000-02-25 |
KR100440544B1 true KR100440544B1 (ko) | 2004-07-15 |
Family
ID=16702466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-1999-0031005A Expired - Fee Related KR100440544B1 (ko) | 1998-07-31 | 1999-07-29 | 양이온 교환수지 제제 |
Country Status (6)
Country | Link |
---|---|
US (1) | US6280717B1 (ko) |
EP (1) | EP0976408B1 (ko) |
KR (1) | KR100440544B1 (ko) |
CA (1) | CA2279788C (ko) |
DE (1) | DE69937214T2 (ko) |
ES (1) | ES2296359T3 (ko) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2003026619A1 (ja) * | 2001-09-26 | 2005-01-06 | 協和醗酵工業株式会社 | 服用性が改善された顆粒 |
CN1845722A (zh) * | 2003-09-03 | 2006-10-11 | 马林克罗特公司 | 粒状缓释制剂及其生产 |
US8282960B2 (en) * | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US7854924B2 (en) * | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
WO2005094384A2 (en) | 2004-03-30 | 2005-10-13 | Ilypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
US9009313B2 (en) * | 2004-07-12 | 2015-04-14 | NetSuite Inc. | Simultaneous maintenance of multiple versions of a web-based business information system |
WO2006101536A1 (en) * | 2004-11-04 | 2006-09-28 | Akina, Inc. | Fast-melting tablets having taste-masking and sustained release properties |
US20060198885A1 (en) * | 2005-02-22 | 2006-09-07 | Sun Pharmaceutical Industries Ltd. | Oral pharmaceutical composition |
US8343546B2 (en) * | 2005-09-13 | 2013-01-01 | Coating Place, Inc. | Ion exchange resin treated to control swelling |
DE112006002617T5 (de) * | 2005-09-30 | 2008-08-28 | Ilypsa Inc., Santa Clara | Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite |
KR20080059265A (ko) * | 2005-09-30 | 2008-06-26 | 일립사, 인코포레이티드 | 포유동물의 위장관으로부터 칼륨 이온을 선택적으로제거하기 위한 방법 및 조성물 |
US7935260B2 (en) * | 2006-08-23 | 2011-05-03 | Pentair Filtration Solutions, Llc | Filtering systems and methods characterized by reduced color throw |
TW200829286A (en) * | 2006-09-06 | 2008-07-16 | Genzyme Corp | Polystyrene sulfonate polymer tablets, their preparation and use |
CN103919792B (zh) * | 2008-08-22 | 2018-03-09 | 瑞立普萨公司 | 交联阳离子交换聚合物、组合物及在治疗方法高钾血症中的应用 |
US20100104527A1 (en) * | 2008-08-22 | 2010-04-29 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
WO2010022380A2 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
WO2010132662A1 (en) * | 2009-05-13 | 2010-11-18 | Relypsa, Inc. | Powder formulations of potassium-binding active agents |
US8741268B2 (en) * | 2009-09-10 | 2014-06-03 | Preventive Technologies, Inc. | Dental prophylactic paste |
ES2441468B1 (es) * | 2012-08-03 | 2014-11-13 | Laboratorios Rubió, S.A. | Composición farmacéutica sólida de resina de intercambio catiónico. |
KR20210005314A (ko) | 2012-10-08 | 2021-01-13 | 리립사, 인크. | 고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제 |
US9433640B2 (en) | 2014-12-23 | 2016-09-06 | Ardelyx, Inc. | Compositions and methods for treating hyperkalemia |
RU2017126229A (ru) * | 2014-12-23 | 2019-01-28 | Арделикс, Инк. | Композиции и способы лечения гиперкалиемии |
WO2019108265A1 (en) * | 2017-11-29 | 2019-06-06 | Dow Global Technologies Llc | Hydrogels based on methylcellulose |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4221778A (en) | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
FR2576213B1 (fr) | 1985-01-21 | 1989-02-24 | Cortial | Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee |
US4804705A (en) | 1986-06-02 | 1989-02-14 | Franz Pum | Gel composition |
IE62100B1 (en) | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
NZ219925A (en) | 1986-07-30 | 1989-06-28 | Pennwalt Corp | Polymer-treated sulphonic acid cationic exchange resin particles |
CA1313135C (en) | 1987-02-09 | 1993-01-26 | The Dow Chemical Company | Cholestyramine composition and process for its preparation |
US5167965A (en) | 1987-02-09 | 1992-12-01 | The Dow Chemical Company | Palatable cholestyramine granules, tablets and methods for preparation thereof |
JPH02286621A (ja) | 1989-04-26 | 1990-11-26 | Mitsubishi Kasei Corp | 経口コレステロール低下剤 |
ES2313739T3 (es) * | 1996-12-20 | 2009-03-01 | Mcneil-Ppc, Inc. | Farmacos antitusigeno administrados por medio de resinas de intercambio ionico. |
JPH1172324A (ja) | 1997-08-29 | 1999-03-16 | Iwasaki Electric Co Ltd | 太陽光自動追尾装置 |
WO1999020285A1 (fr) | 1997-10-16 | 1999-04-29 | Sanwa Kagaku Kenkyusho Co., Ltd. | Preparations de gels contenant un polystyrenesulfonate |
-
1999
- 1999-07-29 KR KR10-1999-0031005A patent/KR100440544B1/ko not_active Expired - Fee Related
- 1999-07-29 US US09/363,047 patent/US6280717B1/en not_active Expired - Lifetime
- 1999-07-30 DE DE69937214T patent/DE69937214T2/de not_active Expired - Lifetime
- 1999-07-30 ES ES99114919T patent/ES2296359T3/es not_active Expired - Lifetime
- 1999-07-30 EP EP99114919A patent/EP0976408B1/en not_active Expired - Lifetime
- 1999-07-30 CA CA002279788A patent/CA2279788C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2296359T3 (es) | 2008-04-16 |
US6280717B1 (en) | 2001-08-28 |
CA2279788A1 (en) | 2000-01-31 |
DE69937214T2 (de) | 2008-07-03 |
EP0976408B1 (en) | 2007-10-03 |
KR20000012062A (ko) | 2000-02-25 |
EP0976408A1 (en) | 2000-02-02 |
CA2279788C (en) | 2008-06-17 |
DE69937214D1 (de) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100440544B1 (ko) | 양이온 교환수지 제제 | |
KR960009182B1 (ko) | 제약정제, 제약과립 및 그의 제조방법 | |
KR101438071B1 (ko) | 약학 조성물 | |
US4687662A (en) | Therapeutic effervescent composition | |
US7132114B2 (en) | Rapidly disintegrating methylcellulose tablets | |
US4747881A (en) | Ingestible aggregate and delivery system prepared therefrom | |
EP0203768B2 (en) | A therapeutic effervescent composition and a method of preparing the same | |
US4818539A (en) | Ingestible aggregate and delivery system prepared therefrom | |
PT693281E (pt) | Formulacoes farmaceuticas de fluoxetina | |
JPS63290822A (ja) | コレスティラミン組成物およびその製法 | |
US4843098A (en) | Ingestible aggregate and delivery system prepared therefrom | |
CN1315483C (zh) | 组合物内在或相关的改进 | |
KR100571085B1 (ko) | 저치환도 히드록시프로필셀룰로오즈 함유 고형 제제 및그의 제조 방법 | |
JPH0717866A (ja) | 医薬組成物 | |
EP1465612A1 (en) | Controlled release tablets of metformin | |
TW550082B (en) | Disintegrant | |
JP3596742B2 (ja) | 陽イオン交換樹脂製剤 | |
JP6154758B2 (ja) | ドライシロップ剤 | |
JP2000119173A (ja) | エリスリトール含有球形顆粒剤及びその製造方法 | |
CN111936168A (zh) | 易服用性颗粒剂及其制造方法 | |
JP2000007555A (ja) | 錠剤およびこの錠剤の製造方法 | |
KR20060119860A (ko) | 용해성과 유동성을 개선한 의약 조성물 | |
JP2002138055A (ja) | 口腔内速崩壊性圧縮成型物およびその製造方法 | |
JP3778240B2 (ja) | 不快な味がマスキングされた造粒組成物及びその製造方法 | |
JP2001328948A (ja) | 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19990729 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20010904 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19990729 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20030926 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20040609 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20040706 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20040706 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20070625 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20080623 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20090623 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20100706 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20110620 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20120620 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20120620 Start annual number: 9 End annual number: 9 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |